This strategy was developed in 2014 and allowed an efficient access to dihomo-isofuran and neurofuran derivatives from the alkenyl and enediol family.
For more details see pdf below and publications 15 and 22
The strategy developed in 2015 allowed an efficient access to phytofuran derivatives from the alkenyl and enediol family.
For more details see publications 28 and 49